News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
567,744 Results
Type
Article (33236)
Company Profile (235)
Press Release (534273)
Section
Business (174527)
Career Advice (1534)
Deals (30035)
Drug Delivery (95)
Drug Development (70769)
Employer Resources (144)
FDA (13430)
Job Trends (12698)
News (294087)
Policy (25795)
Tag
Academia (2219)
Alliances (44917)
Alzheimer's disease (1024)
Approvals (13353)
Artificial intelligence (116)
Bankruptcy (238)
Best Places to Work (9823)
Biotechnology (129)
Breast cancer (80)
Cancer (753)
Career advice (1276)
Cell therapy (165)
Clinical research (56479)
Collaboration (289)
Compensation (104)
COVID-19 (1751)
Cystic fibrosis (74)
Data (690)
Diabetes (120)
Diagnostics (5121)
Drug pricing (90)
Earnings (62240)
Employer resources (130)
Events (87363)
Executive appointments (233)
FDA (13769)
Funding (245)
Gene therapy (130)
GLP-1 (552)
Government (3029)
Healthcare (15839)
Infectious disease (1814)
Inflammatory bowel disease (92)
Interviews (233)
IPO (12739)
Job creations (3129)
Job search strategy (1133)
Layoffs (345)
Legal (5980)
Lung cancer (129)
Manufacturing (134)
Medical device (9827)
Medtech (9830)
Mergers & acquisitions (17317)
Metabolic disorders (357)
Neuroscience (1236)
NextGen Class of 2024 (5782)
Non-profit (3979)
Northern California (943)
Obesity (218)
Opinion (194)
Patents (82)
People (54340)
Pharmaceutical (88)
Phase I (17679)
Phase II (24875)
Phase III (18622)
Pipeline (179)
Postmarket research (2021)
Preclinical (7176)
Radiopharmaceuticals (222)
Rare diseases (174)
Real estate (5160)
Regulatory (17737)
Research institute (2143)
Resumes & cover letters (222)
Southern California (863)
Startups (3143)
United States (9077)
Vaccines (378)
Weight loss (182)
Date
Last 7 days (579)
Last 30 days (2344)
Last 365 days (31434)
2024 (25688)
2023 (34561)
2022 (44263)
2021 (47627)
2020 (46286)
2019 (41396)
2018 (31342)
2017 (28799)
2016 (27949)
2015 (32580)
2014 (25417)
2013 (21173)
2012 (22749)
2011 (23162)
2010 (20732)
Location
Africa (631)
Arizona (113)
Asia (36637)
Australia (5673)
California (2109)
Canada (949)
China (174)
Colorado (88)
Connecticut (80)
Europe (78017)
Florida (310)
Georgia (90)
Illinois (250)
Indiana (162)
Kansas (83)
Maryland (346)
Massachusetts (1714)
Michigan (133)
Minnesota (184)
New Jersey (678)
New York (659)
North Carolina (571)
Northern California (943)
Ohio (105)
Pennsylvania (575)
South America (966)
Southern California (863)
Texas (298)
Washington State (216)
567,744 Results for "lead pharma".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Drug Development
Aphaia Pharma Announces Positive Results from Phase 2 Trial Evaluating its Lead Drug Formulation for Prediabetes Treatment
Aphaia Pharma, a clinical-stage company harnessing precision-targeted drug formulations to restore endogenous endocrine balance for the treatment of obesity and associated metabolic diseases, today announced that its Phase 2 trial evaluating the company’s lead oral glucose formulation for prediabetes treatment met its primary endpoint.
June 20, 2024
·
6 min read
Press Releases
aTyr Pharma’s Lead Therapeutic Candidate Efzofitimod for Pulmonary Sarcoidosis to be Featured in Best of CHEST Journals at CHEST 2024 Annual Meeting
October 8, 2024
·
5 min read
Approvals
ARS Pharma Gets FDA Green Light for First Nasal Spray for Severe Allergic Reactions
ARS Pharma’s neffy on Friday became the first FDA-approved nasal spray to address severe allergic reactions, including those that might lead to life-threatening anaphylaxis.
August 12, 2024
·
2 min read
·
Tristan Manalac
Deals
Apotex Completes Acquisition of Searchlight, a leading Canadian-based Specialty Innovative Branded Pharmaceutical Company
TORONTO, June 3, 2024 /PRNewswire/ - Apotex Inc. announced the successful completion of its acquisition of Searchlight Pharma Inc., a leading Canadian specialty innovative branded pharmaceutical company.
June 3, 2024
·
2 min read
Opinion
Opinion: A Small Pharma Mindset Can Reshape Big Pharma and Improve Patient Care
An appreciation for practicality, independent thinking and patient care can help disrupt the bureaucracy of Big Pharma.
September 12, 2024
·
3 min read
·
Jill Marie Drury
BioCapital
ASCO 2024 | Ascentage Pharma Releases Latest Results from Multiple Clinical Studies of Its Lead Drug Candidates
Ascentage Pharma announced that its four abstracts selected for presentations at the 2024 American Society of Clinical Oncology Annual Meeting are now available on ASCO’s official website.
May 23, 2024
·
16 min read
Biovica Signs Master Service Agreement for TKa Testing with Leading Pharma Company
Biovica International Biovica, active in blood-based cancer monitoring, has signed a master service agreement with a leading tier-1 pharmaceutical company, enabling Biovica to provide its TKa testing assay and testing services.
March 7, 2024
·
1 min read
Business
Astellas Pharma Opens Cambridge Life Sciences Center Featuring Incubator Space
Astellas Pharma’s new life sciences center houses its first U.S.-based SakuLab, an incubator space for external partners, as well as its engineered small molecules unit.
September 6, 2024
·
1 min read
·
Angela Gabriel
Layoffs
Athira Pharma to Lay Off 70% of Workforce
Athira Pharma will cut about 49 positions, including two people in the C-suite. The announcement follows the company’s disappointing results for its investigational Alzheimer’s therapy.
September 23, 2024
·
1 min read
·
Angela Gabriel
Cell and gene therapy
Big Pharma’s Interest Grows in Evolving Cell and Gene Therapy Sector
Large pharmaceutical companies were out in force at this week’s 2024 Cell & Gene Meeting on the Mesa, as they look to expand their presence in the industry.
October 9, 2024
·
4 min read
·
Greg Slabodkin
1 of 56,775
Next